Morgan Stanley Xencor Inc Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Xencor Inc stock. As of the latest transaction made, Morgan Stanley holds 616,207 shares of XNCR stock, worth $15.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

616,207

Previous 621,263 0.81%

Holding current value

$15.6 Million

Previous $11.8 Million 5.37%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$15.7 - $21.65 $79,379 - $109,462	-5,056 Reduced 0.81%	616,207 $12.4 Million
Q2 2024 Oct 17, 2024	SELL	$18.21 - $24.5 $3.3 Million - $4.44 Million	-181,426 Reduced 22.6%	621,263 $11.8 Million
Q2 2024 Aug 14, 2024	SELL	$18.21 - $24.5 $3.3 Million - $4.44 Million	-181,426 Reduced 22.6%	621,263 $11.8 Million
Q1 2024 Oct 17, 2024	BUY	$18.65 - $26.52 $3.38 Million - $4.81 Million	181,426 Added 29.2%	802,689 $17.8 Million
Q1 2024 Aug 16, 2024	BUY	$18.65 - $26.52 $1.08 Million - $1.53 Million	57,642 Added 7.74%	802,689 $17.8 Million
Q1 2024 May 15, 2024	BUY	$18.65 - $26.52 $1.08 Million - $1.53 Million	57,642 Added 7.74%	802,689 $17.8 Million
Q4 2023 Aug 16, 2024	BUY	$16.53 - $21.42 $2.05 Million - $2.65 Million	123,784 Added 19.92%	745,047 $15.8 Million
Q4 2023 Feb 13, 2024	BUY	$16.53 - $21.42 $3.2 Million - $4.14 Million	193,427 Added 35.07%	745,047 $15.8 Million
Q3 2023 Nov 15, 2023	SELL	$20.08 - $25.39 $495,032 - $625,939	-24,653 Reduced 4.28%	551,620 $11.1 Million
Q2 2023 Aug 14, 2023	BUY	$24.77 - $29.9 $264,221 - $318,943	10,667 Added 1.89%	576,273 $14.4 Million
Q1 2023 May 15, 2023	BUY	$25.95 - $36.95 $2.01 Million - $2.87 Million	77,555 Added 15.89%	565,606 $15.8 Million
Q4 2022 Feb 14, 2023	BUY	$24.79 - $30.86 $1.04 Million - $1.3 Million	42,031 Added 9.42%	488,051 $12.7 Million
Q3 2022 Nov 14, 2022	SELL	$24.62 - $32.44 $795,964 - $1.05 Million	-32,330 Reduced 6.76%	446,020 $11.6 Million
Q2 2022 Oct 27, 2022	BUY	$19.74 - $29.01 $2.92 Million - $4.29 Million	147,914 Added 44.76%	478,350 $13.1 Million
Q2 2022 Aug 15, 2022	BUY	$19.74 - $29.01 $2.92 Million - $4.29 Million	147,914 Added 44.76%	478,350 $13.1 Million
Q1 2022 Oct 27, 2022	SELL	$26.68 - $41.63 $3.95 Million - $6.16 Million	-147,914 Reduced 30.92%	330,436 $8.82 Million
Q1 2022 May 13, 2022	BUY	$26.68 - $41.63 $647,897 - $1.01 Million	24,284 Added 7.93%	330,436 $8.82 Million
Q4 2021 Feb 14, 2022	BUY	$33.67 - $43.44 $879,729 - $1.14 Million	26,128 Added 9.33%	306,152 $12.3 Million
Q3 2021 Nov 15, 2021	BUY	$30.65 - $35.68 $8.58 Million - $9.99 Million	280,024 New	280,024 $9.15 Million

Others Institutions Holding XNCR

# of Institutions

216

Shares Held

71.8M

Call Options Held

2.5K

Put Options Held

7.9K

View Full List

About Xencor Inc

Ticker XNCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,698,100
Market Cap $1.51B
Description
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...

More about XNCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account